• Paris+33 (0)1 82 73 10 00

  • Sophia Antipolis+33 (0)4 22 00 01 00

  • London+44 (0)3 333 112 131

    • Fr
    • En
Bluereg
  • About us
    • About BlueReg Pharma Consulting
    • Why work with BlueReg
    • Our Management Team
    • Our Senior Team
    • Social Contribution
    • Affiliations
  • Services
    • Drug Development Consulting
    • Drug Registration
    • Post MA
      • Brexit
    • Pharmacovigilance
    • Publishing
    • Writing
    • CMC
  • Market Specific Services
    • Europe and worldwide markets
    • France
    • UK and Ireland
    • US
  • Documents
  • News & Events
  • Careers
  • BlueReg Watch
  • Contact us
  • Fr
  • En

page

Cancel reply

You must be logged in to post a comment.

Recent Posts

  • Meet us at Dia Europe 2020 in Brussels !
  • UK Medicines and Medical Devices Bill begins passage through Parliament
  • Nitrosamine impurities – are you ready to fulfil your legal obligations as a MAH by March 26th, 2020?
  • BlueReg continues to expand in the US opening its second North American office in Boston.
  • Season’s Greetings

Recent Comments

    Archives

    • February 2020
    • January 2020
    • October 2019
    • September 2019
    • May 2019
    • April 2019
    • January 2019
    • December 2018
    • October 2018
    • September 2018
    • August 2018
    • May 2018
    • April 2018

    Categories

    • Events
    • News

    Discover our last white Paper

    Learn more

    Contact our experts

    Send a message

    About us

    Welcome to BlueReg Group, an international consultancy company specialised in development, regulatory affairs, quality management and pharmacovigilance for the pharmaceutical industry.

     

    We provide tailored consulting services including expert advice with hands-on operational execution and have developed long term partnerships with many clients.

    Links

    • Affiliations and partnerships
    • News
    • Careers
    • Terms of use

    Get in touch

    Gestion des Cookies